Brown Brothers Harriman & Co. increased its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 0.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,351,813 shares of the company’s stock after purchasing an additional 600 shares during the quarter. Brown Brothers Harriman & Co. owned 0.49% of Avantor worth $71,058,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of AVTR. Versant Capital Management Inc increased its position in Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares during the period. Blue Trust Inc. grew its holdings in Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after acquiring an additional 1,391 shares during the period. TFO Wealth Partners LLC raised its position in Avantor by 203,100.0% in the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock worth $46,000 after acquiring an additional 2,031 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new stake in Avantor in the first quarter valued at $93,000. Finally, ORG Partners LLC boosted its position in shares of Avantor by 5,773.0% during the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after purchasing an additional 5,773 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on AVTR. Barclays increased their price target on shares of Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Royal Bank of Canada reiterated an “outperform” rating and set a $31.00 price target on shares of Avantor in a research report on Monday, July 29th. Stifel Nicolaus upped their price target on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, July 29th. TD Cowen boosted their target price on Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Finally, Wells Fargo & Company began coverage on Avantor in a report on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 target price on the stock. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Avantor presently has a consensus rating of “Moderate Buy” and an average price target of $27.40.
Insider Activity
In related news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at $740,372.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company’s stock.
Avantor Stock Performance
Shares of NYSE AVTR opened at $26.88 on Monday. The company has a 50-day simple moving average of $24.42 and a 200-day simple moving average of $24.27. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The company has a market cap of $18.27 billion, a PE ratio of 68.92, a price-to-earnings-growth ratio of 2.75 and a beta of 1.32. Avantor, Inc. has a 12 month low of $16.63 and a 12 month high of $28.00.
Avantor (NYSE:AVTR – Get Free Report) last released its earnings results on Friday, July 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The firm had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.70 billion. On average, equities analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
- Five stocks we like better than Avantor
- Best Stocks Under $5.00
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- Insider Trades May Not Tell You What You Think
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.